Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...
Schools must evolve to teach digital literacy, genetics, and sustainability—preparing students not just for future jobs, but ...
Merck presents positive results from phase 3 LITESPARK-022 trial of Keytruda plus Welireg in certain patients with earlier-stage RCC at 2026 ASCO cancers symposium: Rahway, New Je ...
BATTLE GROUND, WA, UNITED STATES, March 2, 2026 /EINPresswire.com/ -- Most people don’t fully understand what fused ...
As previously reported in the Phase 2 ColdU and SD study, up to 53% of patients with ColdU and 58% with SD achieved complete response (negative provocation test) at Week 12 (primary endpoint analysis) ...
Peter Alan Bingham passed away peacefully on February 9th, 2026 after a decades-long battle with Parkinson’s disease. His wife, Raïna von Waldenburg, along with family and a few close friends, were ...
This month offers a tribute to the prolific filmmaker who died last week at 96 and has a plausible claim to being the greatest documentarian who ever lived.
Discover Sugar Sand Park in Boca Raton, Florida, a free family destination with a three-story playground, kids science museum ...
Step inside a Pennsylvania museum that feels untouched by time, filled with history and captivating artifacts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results